Back to Results
First PageMeta Content
Medicine / Clinical medicine / Cancer / Tyrosine kinase receptors / Breast cancer / Atezolizumab / ROS1 / Triple-negative breast cancer / Anaplastic lymphoma kinase / Trastuzumab emtansine / Entrectinib / Metastatic breast cancer


European Society for Medical Oncology (ESMOCongress Roche Analyst Audio Webcast Monday, 22 October 2018 Welcome Daniel O’Day, CEO Roche Pharmaceuticals
Add to Reading List

Open Document

File Size: 2,40 MB

Share Result on Facebook
UPDATE